このページの翻訳は実験的なもので、現在開発中です。お待ちしております

3B Blackbio Dx マネジメント

マネジメント基準チェック /14

現在、CEO に関する十分な情報がありません。

主要情報

Dhirendra Dubey

最高経営責任者

₹11.2m

報酬総額

CEO給与比率	98.5%
CEO在任期間	3.8yrs
CEOの所有権	9.0%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	9.6yrs

経営陣の近況

Recent updates

CEO報酬分析

3B Blackbio Dx の収益と比較して、Dhirendra Dubey の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	n/a	n/a	₹366m
Mar 31 2024	₹11m	₹11m	₹321m
Dec 31 2023	n/a	n/a	₹317m
Sep 30 2023	n/a	n/a	₹281m
Jun 30 2023	n/a	n/a	₹249m
Mar 31 2023	₹831k	₹720k	₹259m
Dec 31 2022	n/a	n/a	₹263m
Sep 30 2022	n/a	n/a	₹253m
Jun 30 2022	n/a	n/a	₹191m
Mar 31 2022	₹834k	₹720k	₹322m
Dec 31 2021	n/a	n/a	₹443m
Sep 30 2021	n/a	n/a	₹580m
Jun 30 2021	n/a	n/a	₹891m
Mar 31 2021	₹826k	₹720k	₹1b
Dec 31 2020	n/a	n/a	₹965m
Sep 30 2020	n/a	n/a	₹786m
Jun 30 2020	n/a	n/a	₹294m
Mar 31 2020	₹828k	₹720k	₹77m
Dec 31 2019	n/a	n/a	₹62m
Sep 30 2019	n/a	n/a	₹62m
Jun 30 2019	n/a	n/a	₹54m
Mar 31 2019	₹823k	₹720k	₹52m
Dec 31 2018	n/a	n/a	₹45m
Sep 30 2018	n/a	n/a	₹38m
Jun 30 2018	n/a	n/a	₹35m
Mar 31 2018	₹853k	₹720k	₹34m

報酬と市場: Dhirendraの総報酬 ($USD 133.67K ) は、 Indian市場 ($USD 38.99K ) の同規模の企業の平均を上回っています。

報酬と収益: Dhirendraの報酬は過去 1 年間で 20% 以上増加しました。

CEO（最高経営責任者

Dhirendra Dubey (57 yo)

3.8yrs

在職期間

₹11,224,872

報酬

Mr. Dhirendra Kuber Dubey has been Chairman and Managing Director of 3B Blackbio Dx Limited (formerly known as Kilpest India Limited) since December 30, 2020. He also serves as a Whole Time Director of 3B...

取締役

名称	ポジション	在職期間	報酬	所有権
Dhirendra Dubey	Chairman & MD	29.3yrs	₹11.22m	9.05% ₹ 1.0b
Nikhil Dubey	CFO & Whole-Time Director	31.2yrs	₹11.10m	4.18% ₹ 472.8m
Shabbar Husain	Non Executive Independent Director	21.6yrs	₹27.50k	0.029% ₹ 3.3m
Mithla Dubey	Non Executive Director	9.6yrs	₹32.50k	12.37% ₹ 1.4b
Abdul Khan	Non Executive Independent Director	7.1yrs	データなし	0.010% ₹ 1.1m
Harihar Thapak	Independent Non-Executive Director	2.1yrs	₹27.50k	データなし
Rajesh Dubey	Non-Executive Independent Director	less than a year	データなし	データなし

9.6yrs

平均在職期間

69yo

平均年齢

経験豊富なボード: 532067の取締役会は経験豊富であると考えられます ( 9.6年の平均在任期間)。

3B Blackbio Dx マネジメント

マネジメント 基準チェック /14

主要情報

経営陣の近況

3B Blackbio Dx Limited Approves Appointment of Rajesh Dubey as an Independent Director

3B Blackbio Dx Limited, Annual General Meeting, Sep 24, 2024

Kilpest India Limited, Annual General Meeting, Sep 22, 2023

High number of new directors

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Recent updates

3B Blackbio Dx Limited Approves Appointment of Rajesh Dubey as an Independent Director

Dividend increased to ₹3.00

3B Blackbio Dx Limited, Annual General Meeting, Sep 24, 2024

First quarter 2025 earnings released: EPS: ₹13.19 (vs ₹9.60 in 1Q 2024)

New major risk - Share price stability

Investor sentiment improves as stock rises 17%

3B Blackbio Dx Limited to Report Q1, 2025 Results on Aug 12, 2024

New minor risk - Share price stability

Investor sentiment improves as stock rises 38%

Full year 2024 earnings released: EPS: ₹37.46 (vs ₹34.62 in FY 2023)

3B Blackbio Dx Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024

3B Blackbio Dx Limited to Report Q4, 2024 Results on May 29, 2024

Investor sentiment improves as stock rises 15%

Third quarter 2024 earnings released: EPS: ₹9.94 (vs ₹10.27 in 3Q 2023)

3B Blackbio Dx Limited to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: ₹8.86 (vs ₹11.07 in 2Q 2023)

Kilpest India Limited to Report Q2, 2023 Results on Nov 10, 2023

New minor risk - Shareholder dilution

Kilpest India Limited Declares Dividend for the Year Ended March 31, 2023

Upcoming dividend of ₹2.50 per share at 0.3% yield

Kilpest India Limited, Annual General Meeting, Sep 22, 2023

Investor sentiment improves as stock rises 15%

First quarter 2024 earnings released: EPS: ₹9.60 (vs ₹6.28 in 1Q 2023)

Kilpest India Limited to Report Q1, 2024 Results on Aug 11, 2023

Kilpest India Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023

Full year 2023 earnings released: EPS: ₹34.55 (vs ₹42.98 in FY 2022)

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: ₹10.27 (vs ₹8.74 in 3Q 2022)

Kilpest India Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: EPS: ₹11.07 (vs ₹6.84 in 2Q 2022)

Kilpest India Limited to Report Q2, 2023 Results on Nov 12, 2022

High number of new directors

Kilpest India Limited Approves Dividend for the Financial Year 2021-22

Upcoming dividend of ₹2.50 per share

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹6.28 (vs ₹19.89 in 1Q 2022)

Kilpest India Limited to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: EPS: ₹42.89 (vs ₹152 in FY 2021)

Kilpest India Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Less than half of directors are independent

Kilpest India Limited to Report Q4, 2022 Results on May 27, 2022

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Kilpest India Limited Recommends Special Interim Dividend for the Fiscal Year 2021-22

Upcoming dividend of ₹9.00 per share

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹152 (vs ₹10.26 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day low: ₹281

Third quarter 2021 earnings released: EPS ₹26.20 (vs ₹2.31 in 3Q 2020)

Kilpest India Limited to Report Q3, 2021 Results on Feb 05, 2021

Investor sentiment improved over the past week

Kilpest India Limited to Report Q2, 2021 Results on Nov 05, 2020

Kilpest India Limited Restructure Its Operation At 3B Blackbio Biotech India Limited

Kilpest India Limited to Report Q1, 2021 Results on Jul 31, 2020

CEO報酬分析

CEO（最高経営責任者

在職期間

報酬

取締役

平均在職期間

マネジメント基準チェック /14